Retour à toutes les études
TerminéeNCT00190684

Long-Term, Open Label sécurité étude of Atomoxetine Hydrochloride dans Patients, 6 Years et Older avec TDAH

Cette étude est terminée dans plusieurs pays, notamment aux États-Unis, en Australie et en France. Elle évalue atomoxetine Hydrochloride pour le TDAH.

TDAHMédicamentDe 6 à 18 ans

Le registre public indique que cette étude ne recrute pas actuellement. Cette fiche reste disponible à titre informatif. Consulte la source officielle pour vérifier le statut et explore d’autres études qui recrutent.

Choisis ensuite ton pays et vérifie les disponibilités auprès de chaque centre.

En langage simple

Informations clés simplifiées

Que teste cette étude ?

Cette étude cherche à savoir si Atomoxetine Hydrochloride peut être utile pour des personnes vivant avec un TDAH.

Que pourrait impliquer la participation ?

Les participants peuvent recevoir Atomoxetine Hydrochloride, prévoir des visites avec l’équipe de recherche. L’étude indique des lieux en Australie, en Belgique et au Canada.

À qui s’adresse principalement cette étude ?

Cette étude semble s’adresser principalement à des personnes vivant avec un TDAH. Comme elle peut concerner des mineurs, un parent ou responsable légal peut devoir être impliqué.

Que vérifier avant de participer ?

Demande les doses, la surveillance et les effets indésirables possibles, s’il existe un groupe de comparaison, combien de visites ou déplacements sont nécessaires, quel rôle les parents ou responsables légaux doivent jouer.

Ta prochaine étape

Vérifie les détails de l’étude

Consulte la source officielle, puis confirme ces points avec l’équipe de recherche.

Voir la fiche officielle (nouvel onglet)
  • Recrutement et critères

    Un centre recrute-t-il, et qui peut participer ?

  • Visites et temps à prévoir

    Où ont lieu les visites, peut-on en faire à distance et combien de temps faut-il prévoir ?

  • Frais et aides

    Quels frais, remboursements ou indemnités sont prévus ?

Avant de participer

Questions à poser avant de participer

Clarté de l’étude

Éléments à vérifier avant de participer

Date de début de l’étudeaoût 2000
Statut du recrutement
Terminée
Nombre de participants indiqué dans le registre
1 553
Sponsor
Eli Lilly and Company
Type de sponsor
Autre organisation
Type d’étude
Médicament
Type d’intervention
Médicament / traitement médicamenteux
Phase
Phase 3Généralement une étude plus large, conçue pour confirmer l’efficacité et la sécurité dans un groupe plus important.
Lieux
États-Unis, Australie, France, ...
Âge
De 6 à 18 ans
Identifiant officiel du registre
NCT00190684
Titre officiel
Long-Term, Open Label Safety Study of Atomoxetine Hydrochloride in Patients, 6 Years and Older With Attention-Deficit/Hyperactivity Disorder

Demander à HopeStage de m’aider à relire cette étude

Cette fiche ne confirme pas un recrutement ouvert. Nous pouvons t’aider à la comprendre et à explorer d’autres études.

Chargement de la vérification de sécurité...
Référence de l’étude : NCT00190684. On t’aide à relire l’étude, mais on ne décide pas de ton éligibilité médicale.

Vérifier le recrutement et les lieux

Recrutement vérifié auprès du registre par HopeStage le . Les registres peuvent changer. Confirme toujours les disponibilités avec l’équipe de recherche.

Voir la fiche officielle (nouvel onglet)

Le statut de l’étude peut différer de celui de chaque site. Ouvre un pays pour consulter les lieux et leur statut dans le registre.

Australie · 3 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Wallsend, New South Wales
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    South Brisbane, Queensland
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    West Perth, Western Australia
    Statut du site : Non indiqué — à confirmer
Belgique · 2 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Antwerp
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Leuven
    Statut du site : Non indiqué — à confirmer
Canada · 4 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Edmonton, Alberta
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Halifax, Nova Scotia
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Toronto, Ontario
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Québec, Quebec
    Statut du site : Non indiqué — à confirmer
France · 4 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bordeaux
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lyon
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Paris
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Paris
    Statut du site : Non indiqué — à confirmer
Allemagne · 2 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Heiligenstadt/Ofr
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Mannheim
    Statut du site : Non indiqué — à confirmer
Israël · 2 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Holon
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Ness Ziona
    Statut du site : Non indiqué — à confirmer
Italie · 2 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cagliari
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Pisa
    Statut du site : Non indiqué — à confirmer
Pays-Bas · 2 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Groningen
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Utrecht
    Statut du site : Non indiqué — à confirmer
Norvège · 1 site
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Oslo
    Statut du site : Non indiqué — à confirmer
Porto Rico · 2 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Rio Piedras
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    San Juan
    Statut du site : Non indiqué — à confirmer
Afrique du Sud · 3 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Benmore, Sandown
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Garsfontein
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Panorama
    Statut du site : Non indiqué — à confirmer
Suède · 1 site
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Gothenburg
    Statut du site : Non indiqué — à confirmer
Royaume-Uni · 2 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Glasgow, Scotland
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Sheffield, South Yorkshire
    Statut du site : Non indiqué — à confirmer
États-Unis · 70 sites
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Phoenix, Arizona
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    El Centro, California
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Irvine, California
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lafayette, California
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Los Angeles, California
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    San Diego, California
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Spring Valley, California
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Walnut Creek, California
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Norwich, Connecticut
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Boca Raton, Florida
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Gainsville, Florida
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Miami, Florida
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Orlando, Florida
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tallahassee, Florida
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    West Palm Beach, Florida
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Boise, Idaho
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Northbrook, Illinois
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Indianapolis, Indiana
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lafayette, Indiana
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Iowa City, Iowa
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bardstown, Kentucky
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    New Orleans, Louisiana
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Baltimore, Maryland
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cambridge, Massachusetts
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Worcester, Massachusetts
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Detroit, Michigan
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Kalamazoo, Michigan
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Troy, Michigan
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    St Louis, Missouri
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Omaha, Nebraska
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Clementon, New Jersey
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Moorestown, New Jersey
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Piscataway, New Jersey
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Manhasset, New York
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    New Hyde Park, New York
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    New York, New York
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Rochester, New York
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stony Brook, New York
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Chapel Hill, North Carolina
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Charlotte, North Carolina
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cleveland, Ohio
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Columbus, Ohio
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Oklahoma City, Oklahoma
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Portland, Oregon
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Hershey, Pennsylvania
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Media, Pennsylvania
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Philadelphia, Pennsylvania
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Pittsburgh, Pennsylvania
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Rydal, Pennsylvania
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Providence, Rhode Island
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Nashville, Tennessee
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Dallas, Texas
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Galveston, Texas
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lake Jackson, Texas
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Salt Lake City, Utah
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Fairfax, Virginia
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Herndon, Virginia
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Midlothian, Virginia
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Norfolk, Virginia
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Richmond, Virginia
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Vienna, Virginia
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Spokane, Washington
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Marshfield, Wisconsin
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Middleton, Wisconsin
    Statut du site : Non indiqué — à confirmer
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Milwaukee, Wisconsin
    Statut du site : Non indiqué — à confirmer
En pratique

Concrètement

Participer peut contribuer à la recherche. Un bénéfice personnel n’est pas garanti.

Demande à l’équipe de recherche de préciser les activités, la durée et le suivi prévus.

Des sites sont indiqués. Confirme le site concerné et les éventuels déplacements avant de faire des projets.

Important

Pas un avis médical

Informations issues de sources publiques. Tu es le promoteur de cette étude ? Contacte-nous pour mettre à jour cette fiche : hi@hopestage.com

FAQ

Questions sur cette étude

Que cherche à comprendre cette étude ?

Ce résumé doit être relu. Vérifie la fiche officielle de l’étude et contacte l’équipe de recherche pour les détails.

Cette étude implique-t-elle un médicament ?

Cette étude semble être de type médicament / traitement médicamenteux, avec atomoxetine. Les études de phase 3 sont généralement plus larges et cherchent à confirmer l’efficacité et la sécurité dans un groupe plus important.

À qui cette étude pourrait-elle s’adresser ?

Cette étude pourrait concerner des personnes concernées par tdah; âge : De 6 à 18 ans. Les critères semblent plutôt larges, mais tu ne dois pas supposer que tu es éligible. L’équipe d’étude doit confirmer le diagnostic, l’âge, les exclusions, les lieux disponibles et les prochaines étapes.

Qu’est-ce que tu devras concrètement faire ?

Tu pourrais devoir prendre un traitement d’étude et avoir un suivi médical régulier. La présence de lieux d’étude indique qu’au moins une partie de la participation pourrait impliquer un site physique. Demande si certaines étapes peuvent être faites à distance.

Quels effets secondaires, interactions ou changements de traitement dois-tu vérifier ?

Si l’étude implique un médicament, demande s’il est déjà approuvé, expérimental ou testé pour une nouvelle utilisation. Vérifie les effets secondaires possibles, les interactions avec ton traitement actuel, les changements de dose, le suivi prévu et ce qui se passe si tu te sens moins bien. Pour toute étude en santé mentale, demande aussi qui contacter si tu te sens moins bien, si la participation peut affecter ton traitement actuel, si tu peux arrêter, et qui confirme l’éligibilité.

Devras-tu te déplacer ou participer à des visites en présentiel ?

La présence de lieux d’étude indique qu’au moins une partie de la participation pourrait impliquer un site physique. Demande quels sites sont ouverts, combien de visites sont prévues, si des étapes peuvent être faites à distance et si les frais ou compensations sont indiqués.

Qui est derrière cette étude ?

Cette étude est sponsorisée par Eli Lilly and Company, qui semble être une autre organisation. Quand c’est disponible, il peut être utile de vérifier le site du sponsor, les collaborateurs, l’affiliation de l’investigateur et le registre officiel avant de décider. HopeStage ne juge pas la qualité d’un sponsor ou d’un chercheur, mais t’aide à identifier les éléments à vérifier.

Peux-tu encore participer à cette étude ?

Le registre public indique que cette étude ne recrute pas actuellement. Cette fiche reste disponible à titre informatif. Consulte la source officielle pour vérifier le statut et explore d’autres études qui recrutent.

Explorer d’autres études

Tu veux trouver une étude qui peut mieux te correspondre ?

Réponds à quelques questions simples pour explorer les études HopeStage par condition, pays et situation.

Trouver une étude